Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 3,817	$ 3,771	$ 10,385	$ 11,033
Cost of revenue (COR)	1,364	1,325	3,762	3,966
Gross profit	2,453	2,446	6,623	7,067
Research and development (R&D)	386	379	1,142	1,158
Selling, general and administrative (SG&A)	407	399	1,225	1,233
Acquisition charges	51	79	151	238
Restructuring charges	0	0	24	(36)
Operating profit	1,609	1,589	4,081	4,474
Other income (expense), net (OI&E)	27	34	151	122
Interest and debt expense	49	43	142	125
Income before income taxes	1,587	1,580	4,090	4,471
Provision for income taxes	234	155	183	524
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Earnings per common share (EPS):
Basic (in dollars per share)	$ 1.47	$ 1.51	$ 4.22	$ 4.19
Diluted (in dollars per share)	$ 1.45	$ 1.49	$ 4.17	$ 4.12
Average shares outstanding (millions):
Basic (in shares)	917	935	921	937
Diluted (in shares)	929	950	933	953
Diluted EPS:
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Income allocated to RSUs	(6)	(8)	(19)	(25)
Income allocated to common stock for diluted EPS	$ 1,347	$ 1,417	$ 3,888	$ 3,922